Dear lentivirus: We have not forgotten about you and how to impro
January 12, 2024 - Cytiva
Lentiviruses are commonly used for both chimeric antigen recepto
…
Exploring the world of antibodies: mAbs, Fabs, dAbs, and bsAbs
January 12, 2024 - Cytiva
There is a vast array of antibody variants,
…
Interactive eBook - Understand and unlock the potential of digita
December 15, 2023 - Cytiva
Ready for smarter scaling? Explore the possibilities with a
…
How to put mechanistic modeling into practice
December 15, 2023 - Cytiva
Make it happen! Learn ab
…
A deep dive into optimizing AAV capture and polishing to maximize
December 15, 2023 - Cytiva
As demand for AAV vectors grows, so does the need for scalable an
…
Video: Standardize recombinant protein purification process devel
December 15, 2023 - Cytiva
Cytivaâ„¢ Protein Selectâ„¢ resin is an affinity chromatography r
…
Report from the 6th International HTPD Conference
December 1, 2023 - Cytiva
The biggest challenge is still the people and Quantitative Structure-Activity Relationship (QSAR) plus mechanistic modeling were two key take-home messages f
…
Insights from process developers - top challenges in recombinant
December 1, 2023 - Cytiva
You might be one of the many process de
Getting your investigational drug regulatory ready
December 1, 2023 - Cytiva
Navigating regulatory requirements can be an o
…
Democratizing GMP Manufacturing for the New Therapeutic Pipeline
December 1, 2023 - BioPharm International
PharmTech Europe
discusses technology that enable